Lucentis® (Ranibizumab) For Treating Visual Impairment Due To Diabetic Macular Oedema, Study Shows New Evidence

by Medical News Today • 2012/09/06 • 0 Comments

RESTORE extension study demonstrates fully maintained initial vision gains with an average of 13.9 ranibizumab 0...